 |
|
Risk of hepatitis B virus-related hepatocellular carcinoma development is much higher in Koreans than in Taiwanese
Jae-Jun Shim, Jung Wook Kim, Byung-Ho Kim
Korean J Intern Med. 2017;32(5):940-942. Published online 2017 Jul 7 DOI: https://doi.org/10.3904/kjim.2016.180
|
|
Citations to this article as recorded by
 Comment on: Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study
Chien-Hsiang Weng, Philip A. Chan, Joseph Magagnoli, Charles L. Bennett
Drug Safety.2026; 49(2): 253. CrossRef Integrative characterization of human hepatocellular carcinoma‐derived organoids and their HBV‐associated biology
Seo‐Hyeon Kim, YoungRok Choi, Eun Woo Choi, Se Hui Kim, Seung Cheol Oh, Jae Yoon Kim, Su young Hong, Suk Kyun Hong, Kwang‐Woong Lee, Ja‐Lok Ku
Clinical and Translational Medicine.2026;[Epub] CrossRef Factors associated with TDF-to-TAF switching in chronic hepatitis B: A nationwide cohort study in South Korea
Hyemin Ha, Kwang Il Seo, Nam Kyung Je
Journal of Infection and Chemotherapy.2025; 31(12): 102860. CrossRef High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2019; 50(2): 215. CrossRef
|